Neri S, Mariani E, Meneghetti A, Cattini L, Facchini A
Clin Diagn Lab Immunol. 2001; 8(6):1131-5.
PMID: 11687452
PMC: 96238.
DOI: 10.1128/CDLI.8.6.1131-1135.2001.
Purasiri P, Mckechnie A, Heys S, Eremin O
Immunology. 1998; 92(2):166-72.
PMID: 9415022
PMC: 1364054.
DOI: 10.1046/j.1365-2567.1997.d01-2308.x.
Nichols P, Ramsden C, Ward U, Trejdosiewicz L, Ambrose N, Primrose J
Clin Exp Immunol. 1993; 94(1):4-10.
PMID: 8403515
PMC: 1534352.
DOI: 10.1111/j.1365-2249.1993.tb05968.x.
Nichols P, Ward U, Ramsden C, Primrose J
Br J Cancer. 1994; 70(5):946-9.
PMID: 7947102
PMC: 2033527.
DOI: 10.1038/bjc.1994.426.
Lindsay V, Allardyce R
Immunology. 1980; 40(4):571-7.
PMID: 7429543
PMC: 1458097.
Adenine and hypoxanthine metabolism in phythohemagglutinin-stimulated and unstimulated human lymphocytes.
Muller M, Pischek G, Scheiner O, Stemberger H, WIEDERMANN G
Blut. 1980; 40(2):137-45.
PMID: 7353081
DOI: 10.1007/BF01013696.
In vitro augmentation of human natural cytotoxic activity.
Potter M, Moore M
Clin Exp Immunol. 1981; 44(2):332-41.
PMID: 7307338
PMC: 1537332.
Studies on the mechanism of rat natural cellular cytotoxicity and its inhibition by normal rat serum.
Lindsay V, Allardyce R
Immunology. 1981; 43(1):125-31.
PMID: 7251046
PMC: 1555182.
Spontaneous cytotoxicity of human peripheral blood mononuclear cells for the lymphoblastoid cell line CCRF-CEM: augmentation by bacterial lipopolysaccharide.
Schacter B, Kleinhenz M, Edmonds K, Ellner J
Clin Exp Immunol. 1981; 46(3):640-8.
PMID: 7039896
PMC: 1536302.
Immune functions in methyl and ethyl carbamate treated mice.
Luster M, Dean J, Boorman G, Dieter M, HAYES H
Clin Exp Immunol. 1982; 50(1):223-30.
PMID: 6983408
PMC: 1536865.
Proliferative response of lymphocyte subpopulations differing in avidity for sheep red blood cells after stimulation with normal allogeneic and tumour cells.
Matera L, Potter M, Moore M
Immunology. 1981; 44(4):765-72.
PMID: 6947964
PMC: 1554994.
Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy.
Budd G, Bukowski R, Miketo L, Yen-Lieberman B, Proffitt M
Cancer Chemother Pharmacol. 1984; 12(1):39-42.
PMID: 6690072
DOI: 10.1007/BF00255907.
Sézary cells with an unusual phenotype, their modulation with 12-O-tetradecanoyl phorbol-13-acetate (TPA) in vitro, and their relationship to T-cell development.
Kvaloy S, Lindmo T, Davies C, Wisloff F, Godal T
J Clin Immunol. 1983; 3(3):212-21.
PMID: 6604064
DOI: 10.1007/BF00915345.
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm E, Ramsey K, Mazumder A, Wilson D, Djeu J, Rosenberg S
J Exp Med. 1983; 157(3):884-97.
PMID: 6601174
PMC: 2186968.
DOI: 10.1084/jem.157.3.884.
Therapy with high dose recombinant alpha 2 interferon (IFN-alpha 2) produces a depression in natural killer cell cytotoxicity.
Tank B, Marquet R, Weimar W, Westbroek D
Br J Cancer. 1984; 50(2):227-30.
PMID: 6466539
PMC: 1976876.
DOI: 10.1038/bjc.1984.167.
Natural killer cell activity in renal transplant recipients receiving cyclosporine.
Gui X, Rinaldo Jr C, Ho M
Infect Immun. 1983; 41(3):965-70.
PMID: 6309674
PMC: 264595.
DOI: 10.1128/iai.41.3.965-970.1983.
Stimulation natural cytotoxic activity in mixed cell cultures and by culture supernatants containing interferon.
Potter M, Moore M, Morris A
Immunology. 1982; 46(2):401-9.
PMID: 6177626
PMC: 1555369.
Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
Grimm E, Mazumder A, Zhang H, Rosenberg S
J Exp Med. 1982; 155(6):1823-41.
PMID: 6176669
PMC: 2186695.
DOI: 10.1084/jem.155.6.1823.
Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon.
Herberman R, Ortaldo J, Rubinstein M, Pestka S
J Clin Immunol. 1981; 1(3):149-53.
PMID: 6174540
DOI: 10.1007/BF00922756.
Factors affecting the spontaneous cell-mediated cytotoxicity of intestinal mononuclear cells.
Gibson P, Hermanowicz A, Jewell D
Immunology. 1984; 53(2):267-74.
PMID: 6092269
PMC: 1454837.
